Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
TrivarX LimitedTelephone
61.3.6189.1155
Address
647 Beaufort Street Mt. Lawley, Western Australia (WA) 6050
Description
TrivarX Ltd. engages in clinical research, product development, and early-stage commercialization of mental health technology. Its product is used to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in 1998 and is headquartered in South Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.05
Trade Value (12mth)
AU$5,622.00
1 week
-8.33%
1 month
-12%
YTD
-26.67%
1 year
10%
All time high
172.93
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
-$1m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-150.50
Quick Ratio
0.00
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Technology
Next Company Report Date
28-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
29 August 24 |
Appendix 4E - Preliminary Final Report
×
Appendix 4E - Preliminary Final Report |
20 August 24 |
Notification of cessation of securities - TRI
×
Notification of cessation of securities - TRI |
31 July 24 |
June 2024 Quarterly Activities Report and Appendix 4C
×
June 2024 Quarterly Activities Report and Appendix 4C |
30 July 24 |
Positive Results from Phase 2 SAMDE Study
×
Positive Results from Phase 2 SAMDE Study |
30 July 24 |
TechKnow Invest Roadshow presentation and livestream links
×
TechKnow Invest Roadshow presentation and livestream links |
30 July 24 |
Final Director's Interest Notice - Tom Young
×
Final Director's Interest Notice - Tom Young |
30 July 24 |
Initial Director's Interest Notice - Tony Keating
×
Initial Director's Interest Notice - Tony Keating |
29 July 24 |
Appointment of Dr Tony Keating & Resignation of Dr Tom Young
×
Appointment of Dr Tony Keating & Resignation of Dr Tom Young |
29 July 24 |
Trading Halt
×
Trading Halt |
12 July 24 |
Change in substantial holding
×
Change in substantial holding |
10 July 24 |
Completion of Phase 2 SAMDE Trial
×
Completion of Phase 2 SAMDE Trial |
10 July 24 |
Application for quotation of securities - TRI
×
Application for quotation of securities - TRI |
10 July 24 |
Notification regarding unquoted securities - TRI
×
Notification regarding unquoted securities - TRI |
10 July 24 |
Notification regarding unquoted securities - TRI
×
Notification regarding unquoted securities - TRI |
10 July 24 |
Application for quotation of securities - TRI
×
Application for quotation of securities - TRI |
10 July 24 |
Application for quotation of securities - TRI
×
Application for quotation of securities - TRI |
10 July 24 |
Cleansing Notice
×
Cleansing Notice |
10 July 24 |
Change of Director's Interest Notice - Chris Ntoumenopoulos
×
Change of Director's Interest Notice - Chris Ntoumenopoulos |
10 July 24 |
Change of Director's Interest Notice - David Trimboli
×
Change of Director's Interest Notice - David Trimboli |
09 July 24 |
Proposed issue of securities - TRI
×
Proposed issue of securities - TRI |
05 July 24 |
Results of General Meeting
×
Results of General Meeting |
20 June 24 |
TrivarX SAMDE Trial Update
×
TrivarX SAMDE Trial Update |
11 June 24 |
Update - Proposed issue of securities - TRI
×
Update - Proposed issue of securities - TRI |
04 June 24 |
Letter to Shareholders & Notice of GM & Proxy Form
×
Letter to Shareholders & Notice of GM & Proxy Form |
04 June 24 |
Proposed issue of securities - TRI
×
Proposed issue of securities - TRI |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.